Colorectal clinical trials: What is on the horizon?

Daniel H. Ahn, Richard M. Goldberg

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Substantial progress has been made in the treatment of colorectal cancer, where more effective therapies have led to improved outcomes in patients with advanced disease. However, the 5-year overall survival rate remains poor. Genomic sequencing has allowed us to understand that colorectal cancer is a heterogeneous disease, where tumor-specific variants affect the prognosis and outcomes in patients. This has shaped the future directions of treatment and the development of clinical trials, including the incorporation of novel targeted therapies and investigations into the role of immunotherapy in colorectal cancer.

Original languageEnglish (US)
Pages (from-to)525-531
Number of pages7
JournalFuture Oncology
Issue number4
StatePublished - Feb 2016


  • colorectal cancer
  • immunotherapy
  • next-generation sequencing
  • targeted therapy

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Colorectal clinical trials: What is on the horizon?'. Together they form a unique fingerprint.

Cite this